News
- Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology
00:30 - GlobeNewswire
-
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
00:15 - GlobeNewswire
-
- Avista files rate proposals in Washington that would not impact customer bills
10/30/2020 / 23:30 - GlobeNewswire
-
- FHLBank San Francisco Releases September 2020 Cost of Funds Index
10/30/2020 / 23:23 - GlobeNewswire
-
- Westbury Bancorp, Inc. Reports Net Income for the Three Months and Year Ended September 30, 2020
10/30/2020 / 22:05 - GlobeNewswire
-
- Sanatana Signs Definitive Watershed Royalty Assignment Agreement
10/30/2020 / 22:01 - Newsfile Corp
-
- "Four Reasons for Ohio": Despite Nearly 66,000 Taat Units Sold Pre-Launch in Other Markets, Taat CEO Gives Video Statement Regarding Decision to Launch Taat in Ohio
10/30/2020 / 22:00 - GlobeNewswire
-
- First Savings Financial Group, Inc. Reports Financial Results For the Fiscal Year Ended September 30, 2020
10/30/2020 / 22:00 - GlobeNewswire
-
- UTStarcom Reports Unaudited Financial Results for First Half of 2020
10/30/2020 / 22:00 - GlobeNewswire
-
- ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm– PGEN, XON
10/30/2020 / 21:58 - GlobeNewswire
Real-time